Huron Consulting Group (NASDAQ:HURN) Updates FY 2025 Earnings Guidance

Huron Consulting Group (NASDAQ:HURN) updated its FY 2025 earnings guidance on Tuesday. The company provided earnings per share guidance of 6.800-7.600 for the period, compared to the consensus earnings per share estimate of 6.950. The company issued revenue guidance of $1.6 billion-$1.7 billion, compared to the consensus revenue estimate of $1.6 billion.

Analyst Ratings Changes

A number of equities analysts have recently issued reports on HURN shares. Barrington Research increased their target price on Huron Consulting Group from $137.00 to $142.00 and gave the stock an “outperform” rating in a report on Monday, November 4th. Wedbush started coverage on Huron Consulting Group in a report on Monday, February 3rd. They issued an “outperform” rating for the company. Benchmark reissued a “buy” rating and issued a $140.00 target price on shares of Huron Consulting Group in a report on Wednesday, October 30th. Finally, StockNews.com raised Huron Consulting Group from a “hold” rating to a “buy” rating in a report on Thursday, October 31st. Five research analysts have rated the stock with a buy rating, According to MarketBeat.com, the company has an average rating of “Buy” and a consensus price target of $133.00.

Huron Consulting Group Price Performance

NASDAQ HURN traded up $0.03 during trading hours on Tuesday, reaching $125.33. 396,891 shares of the company’s stock were exchanged, compared to its average volume of 110,694. The stock has a market cap of $2.22 billion, a PE ratio of 27.25 and a beta of 0.59. Huron Consulting Group has a one year low of $84.26 and a one year high of $133.96. The firm has a fifty day moving average of $125.65 and a 200-day moving average of $117.22. The company has a current ratio of 1.61, a quick ratio of 1.61 and a debt-to-equity ratio of 0.82.

Huron Consulting Group (NASDAQ:HURN) last released its quarterly earnings results on Tuesday, February 25th. The business services provider reported $1.90 EPS for the quarter, topping analysts’ consensus estimates of $1.52 by $0.38. Huron Consulting Group had a return on equity of 21.51% and a net margin of 5.80%. On average, equities research analysts predict that Huron Consulting Group will post 6.1 earnings per share for the current fiscal year.

Insider Buying and Selling at Huron Consulting Group

In other Huron Consulting Group news, Director James H. Roth sold 2,000 shares of the stock in a transaction on Wednesday, December 4th. The stock was sold at an average price of $123.70, for a total value of $247,400.00. Following the transaction, the director now directly owns 52,825 shares in the company, valued at approximately $6,534,452.50. This trade represents a 3.65 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director H Eugene Lockhart sold 1,042 shares of the stock in a transaction on Monday, February 3rd. The shares were sold at an average price of $125.15, for a total value of $130,406.30. Following the completion of the transaction, the director now owns 24,672 shares in the company, valued at $3,087,700.80. The trade was a 4.05 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 8,584 shares of company stock worth $1,067,539. Insiders own 2.02% of the company’s stock.

About Huron Consulting Group

Huron Consulting Group Inc, a professional services firm, provides consultancy services in the United States and internationally. It operates through three segments: Healthcare, Education, and Commercial. The Healthcare segment provides financial and operational performance improvement consulting services; digital offerings, spanning technology and analytic-related services; software products; organizational transformation services; revenue cycle managed and outsourcing services; financial and capital advisory consulting services; and strategy and innovation consulting services to national and regional health systems, academic and community health systems, federal health system, public, children’s and critical access hospitals, physician practices and medical groups, payors, and long-term care or post-acute providers.